Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
暂无分享,去创建一个
G. Capellá | R. Salazar | A. Villanueva | E. Martínez-Balibrea | D. Molleví | J. Guardiola | A. Soriano | Natalia Guillén Díaz-Maroto | M. Martínez-Villacampa | M. Berdiel-Acer | S. Gonçalves-Ribeiro | Samuel Gonçalves-Ribeiro | N. G. Díaz-Maroto
[1] E. Musulen,et al. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines , 2015, PloS one.
[2] Camille Stephan-Otto Attolini,et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.
[3] R. Sanz-Pamplona,et al. Intrinsic cancer subtypes-next steps into personalized medicine , 2015, Cellular Oncology.
[4] R. Sanz-Pamplona,et al. Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information , 2014, Molecular oncology.
[5] 長﨑 高也. Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis : anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction , 2014 .
[6] A. Takahashi,et al. The BRCA2 gene is a potential molecular target during 5-fluorouracil therapy in human oral cancer cells. , 2014, Oncology reports.
[7] B. Zhai,et al. Up‐regulation of survivin by AKT and hypoxia‐inducible factor 1α contributes to cisplatin resistance in gastric cancer , 2014, The FEBS journal.
[8] Y. Miao,et al. Stromal–Epithelial Crosstalk Provides a Suitable Microenvironment for the Progression of Ovarian Cancer Cells in Vitro , 2013, Cancer investigation.
[9] A. G. de Herreros,et al. Functional Heterogeneity of Cancer-Associated Fibroblasts from Human Colon Tumors Shows Specific Prognostic Gene Expression Signature , 2013, Clinical Cancer Research.
[10] Qiang Yu,et al. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy. , 2013, Cancer discovery.
[11] C. Arteaga,et al. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation , 2013, Breast Cancer Research.
[12] S. Groshen,et al. Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma. , 2013, Cancer research.
[13] Mira Ayadi,et al. Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value , 2013, PLoS medicine.
[14] A. Martelli,et al. The emerging multiple roles of nuclear Akt. , 2012, Biochimica et biophysica acta.
[15] J. Delord,et al. Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death , 2012, International journal of molecular sciences.
[16] T. Golub,et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion , 2012, Nature.
[17] A. Opstal,et al. Inhibition of protein kinase B activity induces cell cycle arrest and apoptosis during early G1 phase in CHO cells , 2012, Cell biology international.
[18] Li Lin,et al. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells. , 2011, Cancer research.
[19] R. Salazar,et al. Hepatic carcinoma-associated fibroblasts promote an adaptative response in colorectal cancer cells that inhibit proliferation and apoptosis: nonresistant cells die by nonapoptotic cell death. , 2011, Neoplasia.
[20] P. D. De Angelis,et al. DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status. , 2011, International journal of oncology.
[21] Carlos L. Arteaga,et al. Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors , 2011, Proceedings of the National Academy of Sciences.
[22] Chi-Ying F. Huang,et al. Insulin-like growth factor 1 mediates 5-fluorouracil chemoresistance in esophageal carcinoma cells through increasing survivin stability , 2011, Apoptosis.
[23] Sarat Chandarlapaty,et al. AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity. , 2011, Cancer cell.
[24] C. Garlanda,et al. The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker , 2010, Journal of Translational Medicine.
[25] S. Leung,et al. Biomarkers , Genomics , Proteomics , and Gene Regulation Subcellular Localization of Activated AKT in Estrogen Receptor-and Progesterone Receptor-Expressing Breast Cancers Potential Clinical Implications , 2010 .
[26] Robert A. Gatenby,et al. Environment-mediated drug resistance: a major contributor to minimal residual disease , 2009, Nature Reviews Cancer.
[27] Timothy C Wang,et al. Inflammation and cancer: IL-6 and STAT3 complete the link. , 2009, Cancer cell.
[28] K. Pienta,et al. CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulation* , 2008, Journal of Biological Chemistry.
[29] Stephen S. Taylor,et al. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. , 2008, Cancer cell.
[30] B. Zhivotovsky,et al. Death through a tragedy: mitotic catastrophe , 2008, Cell Death and Differentiation.
[31] B. Hemmings,et al. PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. , 2008, Molecular cell.
[32] T. Kowalik,et al. Activated checkpoint kinase 2 provides a survival signal for tumor cells. , 2006, Cancer research.
[33] D. Altieri. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. , 2006, Current opinion in cell biology.
[34] S. Wheatley,et al. Separating the Anti-apoptotic and Mitotic Roles of Survivin* , 2006, Journal of Biological Chemistry.
[35] Ping Zhang,et al. Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line , 2006, BMC Cancer.
[36] D. Rouillard,et al. Cell cycle arrest and apoptosis induced by oxaliplatin (L-OHP) on four human cancer cell lines. , 2006, Anticancer research.
[37] Wei Zhang,et al. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. , 2005, The American journal of pathology.
[38] T. Koyama,et al. p38 MAP kinase plays a role in G2 checkpoint activation and inhibits apoptosis of human B cell lymphoma cells treated with etoposide , 2005, Apoptosis.
[39] T. Nagayasu,et al. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors , 2005, Journal of Clinical Pathology.
[40] Kurt Zatloukal,et al. Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. , 2005, Neoplasia.
[41] M. Uhler,et al. Phosphatidylinositol 3‐kinase and Akt effectors mediate insulin‐like growth factor‐I neuroprotection in dorsal root ganglia neurons , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[42] R. Medema,et al. Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. , 2004, Molecular cell.
[43] P. Morin,et al. Molecular mechanisms of platinum resistance: still searching for the Achilles' heel. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[44] W. Dalton,et al. Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death , 2003, Oncogene.
[45] A. Martelli,et al. Threonine 308 phosphorylated form of akt translocates to the nucleus of PC12 cells under nerve growth factor stimulation and associates with the nuclear matrix protein nucleolin , 2003, Journal of cellular physiology.
[46] D. Altieri,et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. , 2002, Journal of cell science.
[47] Hui Zhang,et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[48] D R Alessi,et al. Mitogenic Activation, Phosphorylation, and Nuclear Translocation of Protein Kinase Bβ* , 1997, The Journal of Biological Chemistry.
[49] P. Cheah. Recent advances in colorectal cancer genetics and diagnostics. , 2009, Critical reviews in oncology/hematology.
[50] R. Moriggl,et al. Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. , 2007, Neoplasia.